Lung Cancer Research Foundation (LCRF) Award on Advancing Breakthroughs in ALK-Positive Lung Cancer 2026

Get latest opportunities sent your Inbox

---

Join our Telegram Channel Follow us on WhatsApp

About LCRF - Award on Advancing Breakthroughs in ALK-Positive Lung Cancer

The Lung Cancer Research Foundation (LCRF) has launched a funding opportunity to support innovative research focused on ALK (Anaplastic Lymphoma Kinase) rearrangements as drivers of lung cancer and the development of new treatment strategies for patients with ALK-positive lung cancer.The program encourages translational research that improves understanding of disease progression, treatment resistance, tumor biology, and emerging therapeutic approaches. Researchers are invited to explore scientific questions that can ultimately improve clinical outcomes and quality of life for patients living with ALK-positive lung cancer.The initiative supports projects that bridge laboratory discoveries and clinical application, accelerating the development of more effective precision medicine approaches.

• Sponsor Organisation: Lung Cancer Research Foundation (LCRF)

Benefits of LCRF - Award on Advancing Breakthroughs in ALK-Positive Lung Cancer

• These awards provide a maximum of $300,000 in funding over a period of two years.

LCRF - Award on Advancing Breakthroughs in ALK-Positive Lung Cancer Requirements

Applications are welcomed from researchers at any career stage.

Eligible applicants include researchers affiliated with:

• Non-profit academic institutions.
• Non-profit research institutions.

Additional eligibility requirements include:

• Applicants may be based in the United States or internationally.
• Citizenship or residency restrictions do not apply.
• Industry collaborators may participate in research teams.
• Applicants must not receive overlapping funding or salary support from another active LCRF grant.
• Only one application per funding track is permitted during the grant cycle.

Application Date and Process

• Click on the link to the application website to apply.

Application Deadline

15 July, 2026

Opportunity Application

View details of LCRF - Award on Advancing Breakthroughs in ALK-Positive Lung Cancer

Apply for LCRF - Award on Advancing Breakthroughs in ALK-Positive Lung Cancer